Back to NVSEF
Douglas Lane & Associates, LLC → NVSEF
Douglas Lane & Associates, LLC NVSEF Position History
Novartis AG
Quarters held
5
Latest value
$18.9M
Q3 2026
Peak value
$22.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $20.1M |
| Q4 2025 | $20.8M |
| Q1 2026 | $22.2M |
| Q2 2026 | $22M |
| Q3 2026 | $18.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $18.9M | 132.3K | — | — |
| Q2 2026 | $22M | 140.2K | — | — |
| Q1 2026 | $22.2M | 145.1K | — | — |
| Q4 2025 | $20.8M | 151.0K | — | — |
| Q3 2025 | $20.1M | 156.4K | — | — |
Other funds holding NVSEF
$1.9B
$1.7B
$1.7B
$1.4B
$1.4B
$1.3B